Skip to main content
. 2019 Nov 27;16:150. doi: 10.1186/s12984-019-0620-y

Table 1.

Clinical and demographic details as well as training parameters of the patients recruited for the study

Subject Age [years] Sex Dystonia Drugs / DBSa Tested arm BAD armb Figure-8 size (circle radius [cm]) Target Speeds [bpm]c BF target muscle
P1 10 F I Trihexyphenidyl Right 1 4 100; 80; 60 AD
P2 10 F I Trihexyphenidyl Right 1 4 80; 60; 50 FCU
P3 16 M I None Right 1 4 100; 80; 60 AD
P4 17 F I DBS Right 1 4 100; 80; 60 FCU
P5 19 M I Trihexyphenidyl Right 1 4 100; 80; 60 ECR
P6 8 M I Trihexyphenidyl Right 1 4 80; 60; 50 FCU
P7 8 M I L-Dopa/Carbidopa Right 1 4 100; 80; 60 FCU
S1 14 M II None Right 2 4 60; 50; 40 LD
S2 10 M II None Right 2 4 60; 50; 40 ECR
S3 8 M II None Right 1 4 20 ECR
S4 16 F II DBS Right 3 7 uncontrolled BIC
S5 13 M II Trihexyphenidyl Left 3 4 40; 30; 20 LD
S6 6 F II None Right 1 4 80; 60; 40 FCU
S7 8 F II Trihexyphenidyl Right 1 7 30; 40 AD

a) DBS: Deep Brain Stimulation. b) BAD of the dominant/tested arm: 0 (absent) - 4 (severe). c) Among target speed, the speed used for training is highlighted in bold.